Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Persistent alanine aminotransferase elevation among the general Iranian population: prevalence and causes
AIM: To determine the prevalence and causes of persistently elevated alanine
aminotransferase (ALT) levels among the general population in northern Iran. METHODS: A …
aminotransferase (ALT) levels among the general population in northern Iran. METHODS: A …
The prevalence of metabolic syndrome in non-alcoholic fatty liver disease; a population-based study
BACKGROUND Some evidence, not in large study populations, suggests that nonalcoholic
fatty liver disease (NAFLD) and metabolic syndrome (MetS) share common interactions. We …
fatty liver disease (NAFLD) and metabolic syndrome (MetS) share common interactions. We …
How much weight loss is effective on nonalcoholic fatty liver disease?
Background Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease
worldwide with no specific treatment. Weight loss is the most effective therapeutic strategy in …
worldwide with no specific treatment. Weight loss is the most effective therapeutic strategy in …
The importance of precision medicine in type 2 diabetes mellitus (T2DM): from pharmacogenetic and pharmacoepigenetic aspects
Background: Type 2 Diabetes Mellitus (T2DM) is a worldwide disorder as the most important
challenges of health-care systems. Controlling the normal glycaemia greatly profit long-term …
challenges of health-care systems. Controlling the normal glycaemia greatly profit long-term …
Steatosis and steatohepatitis in postmortem material from Northwestern Greece
AIM: To determine the prevalence of steatosis and steatohepatitis in a series of autopsies in
Northwestern Greece. METHODS: Liver biopsy material from a total of 600 autopsies …
Northwestern Greece. METHODS: Liver biopsy material from a total of 600 autopsies …
Prevalence of nonalcoholic steatohepatitis in Iran: a population based study
BACKGROUND Non-alcoholic fatty liver disease/steatohepatitis (NAFLD/NASH) is the most
common form of chronic liver disease worldwide and is no longer considered a benign …
common form of chronic liver disease worldwide and is no longer considered a benign …
Deregulated hepatic micro RNA s underlie the association between non‐alcoholic fatty liver disease and coronary artery disease
Abstract Background & Aims Non‐alcoholic fatty liver disease (NAFLD) appears to be a new
risk factor for the development of coronary artery disease (CAD). Members of a class of non …
risk factor for the development of coronary artery disease (CAD). Members of a class of non …
[PDF][PDF] Sampling error in histopathology findings of nonalcoholic fatty liver disease: a post mortem liver histology study
BACKGROUND: Many clinical trials and natural history studies on nonalcoholic fatty liver
disease (NAFLD) and nonalcoholic steatohepatitis (NASH) rely heavily on liver histology to …
disease (NAFLD) and nonalcoholic steatohepatitis (NASH) rely heavily on liver histology to …
Nonalcoholic fatty liver: the association with metabolic abnormalities, body mass index and central obesity—a population-based study
Background: To assess the prevalence of nonalcoholic fatty liver (NAFL) in Iran and to
evaluate correlates of NAFL in categories of body mass index (BMI). Methods: Using a …
evaluate correlates of NAFL in categories of body mass index (BMI). Methods: Using a …
Prevalence of non-alcoholic fatty liver disease in patients with coronary artery disease
B Baharvand-Ahmadi, K Sharifi… - ARYA …, 2016 - pmc.ncbi.nlm.nih.gov
BACKGROUND Several common metabolic risk factors contribute to development of both
non-alcoholic fatty liver disease (NAFLD) and coronary artery disease (CAD). The aim was …
non-alcoholic fatty liver disease (NAFLD) and coronary artery disease (CAD). The aim was …